As of 2025-10-28, the Relative Valuation of Oncolytics Biotech Inc (ONC.TO) is (0.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.42 CAD, the upside of Oncolytics Biotech Inc based on Relative Valuation is -102.2%.
The range of the Relative Valuation is (0.02) - (0.06) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.2x | 0.1x |
| Forward P/E multiples | 0.1x - 0.2x | 0.1x |
| Fair Price | (0.02) - (0.06) | (0.03) |
| Upside | -101.8% - -104.4% | -102.2% |
| Date | P/E |
| 2025-08-22 | -4.55 |
| 2025-08-21 | -4.45 |
| 2025-08-20 | -4.48 |
| 2025-08-19 | -4.39 |
| 2025-08-18 | -4.55 |
| 2025-08-15 | -4.77 |
| 2025-08-14 | -4.29 |
| 2025-08-13 | -4.48 |
| 2025-08-12 | -3.75 |
| 2025-08-11 | -3.78 |
| 2025-08-08 | -3.78 |
| 2025-08-07 | -4.04 |
| 2025-08-06 | -4.16 |
| 2025-08-05 | -4.23 |
| 2025-08-01 | -4.39 |
| 2025-07-31 | -4.48 |
| 2025-07-30 | -4.61 |
| 2025-07-29 | -4.55 |
| 2025-07-28 | -4.84 |